n-dichlorofluoromethylthio-n',n'-dimethyl-n-p-tolylsulfamide has been researched along with Metabolic Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aldirawi, H; Dybala, MP; Hara, M; Haro, F; Kirkley, AG; Regnier, SM; Ruiz, D; Sargis, RM | 1 |
| El-Hashani, E; Hayes, ET; Huang, L; Johnson, DN; Kamau, W; Kirkley, AG; Massad, NL; Neel, BA; Regnier, SM; Sargis, RM; Thomas, CC; Williams, AK; Ye, H; Zhang, C; Zhang, X | 1 |
2 other study(ies) available for n-dichlorofluoromethylthio-n',n'-dimethyl-n-p-tolylsulfamide and Metabolic Diseases
| Article | Year |
|---|---|
Developmental exposure to the endocrine disruptor tolylfluanid induces sex-specific later-life metabolic dysfunction.
Topics: Adiposity; Animals; Endocrine Disruptors; Female; Insulin Resistance; Maternal Exposure; Metabolic Diseases; Mice; Mice, Inbred C57BL; Pregnancy; Prenatal Exposure Delayed Effects; Receptors, Glucocorticoid; Sex Characteristics; Sulfonamides; Toluidines | 2019 |
Dietary exposure to the endocrine disruptor tolylfluanid promotes global metabolic dysfunction in male mice.
Topics: Adiponectin; Adiposity; Animals; Circadian Rhythm; Eating; Endocrine Disruptors; Energy Metabolism; Gene Expression Regulation; Glucose Tolerance Test; Insulin; Insulin Resistance; Leptin; Male; Metabolic Diseases; Mice; Oligonucleotide Array Sequence Analysis; RNA; Sulfonamides; Toluidines; Weight Gain | 2015 |